Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FNS5E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,925
Award facts
- Contract value 100% obligated
- $20,924.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,924.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Dupixent 300 mg/2 mL pen injections (2 mL units). This is a non-set-aside competitive award with a completion date of January 30, 2026, and performance at the awardee's facility in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999.99 million through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated extensive capability in fulfilling DLA medical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. The company's parent organization, Cencora, Inc., holds the primary IDC with the DLA and competes on a full and open basis for federal pharmaceutical contracts, supplying essential medications to military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26FNS5E?
SPE2DR26FNS5E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FNS5E worth?
The government has obligated $20,925 on SPE2DR26FNS5E.
Is contract SPE2DR26FNS5E an order under another contract?
Yes. SPE2DR26FNS5E is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNS5E competed?
The extent of competition for SPE2DR26FNS5E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award